Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-17-002420
Filing Date
2017-03-14
Accepted
2017-03-14 17:00:16
Documents
1
Period of Report
2017-03-09

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3496
  Complete submission text file 0001493152-17-002420.txt   5044
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Reporting) CIK: 0001542484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 17688783